Chandra Bhagat Pharma Ltd vs Lyka Labs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Chandra Bhagat Pharma Ltd is ₹ 33 as of 27 Apr 15:30 . The P/E Ratio of Chandra Bhagat Pharma Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Lyka Labs Ltd changed from 10 on March 2022 to 45.1 on March 2025 . This represents a CAGR of 45.73% over 4 years The Market Cap of Chandra Bhagat Pharma Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Lyka Labs Ltd changed from ₹ 74.59 crore on March 2021 to ₹ 360.29 crore on March 2025 . This represents a CAGR of 37.02% over 5 years The revenue of Chandra Bhagat Pharma Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Lyka Labs Ltd for the Dec '25 is ₹ 31.89 crore as compare to the Sep '25 revenue of ₹ 37.75 crore. This represent the decline of -15.52% The ebitda of Chandra Bhagat Pharma Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Lyka Labs Ltd for the Dec '25 is ₹ 2.81 crore as compare to the Sep '25 ebitda of ₹ -1.45 crore. This represent the decline of -293% The net profit of Chandra Bhagat Pharma Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Lyka Labs Ltd changed from ₹ 1.29 crore to ₹ -0.15 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Chandra Bhagat Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Lyka Labs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Chandra Bhagat Pharma Ltd

Chandra Bhagat Pharma Limited was incorporated as a Private Limited Company with the name 'Chandra Bhagat Pharma Private Limited' at Mumbai on March 10, 2003.
Consequent upon the conversion of the Company from Private Limited Company to Public Limited Company, the name of the Company was changed to 'Chandra Bhagat Pharma Limited' on March 20, 2019. The Company incorporated in March, 2003 by Mr. Hemant Bhagat and Late.
Shree Chandravadan Bhagat.
On April 1, 2003, the Company acquired the going concern business of M/s.
Chandra Bhagat Corporation, partnership firm along with all its assets and liabilities.

About Lyka Labs Ltd

Initially manufacturing formulations, Lyka Labs Limited brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. '83.
It also added a range of ayurvedic and animal health care products over the years.
In 1990, it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson, US; Airsep Corporation, US; Coloplast, Denmark; and Terumo Corporation, Japan.
Lyka Exports is the subsidiary of the company.
The Company is engaged in the development, manufacture and marketing of quality finished dosages. The company offers a broad range of antibiotics used as life-savers and to treat minor infections.

FAQs for the comparison of Chandra Bhagat Pharma Ltd and Lyka Labs Ltd

Which company has a larger market capitalization, Chandra Bhagat Pharma Ltd or Lyka Labs Ltd?

Market cap of Chandra Bhagat Pharma Ltd is 24 Cr while Market cap of Lyka Labs Ltd is 209 Cr

What are the key factors driving the stock performance of Chandra Bhagat Pharma Ltd and Lyka Labs Ltd?

The stock performance of Chandra Bhagat Pharma Ltd and Lyka Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Chandra Bhagat Pharma Ltd and Lyka Labs Ltd?

As of May 5, 2026, the Chandra Bhagat Pharma Ltd stock price is INR ₹33.0. On the other hand, Lyka Labs Ltd stock price is INR ₹58.72.

How do dividend payouts of Chandra Bhagat Pharma Ltd and Lyka Labs Ltd compare?

To compare the dividend payouts of Chandra Bhagat Pharma Ltd and Lyka Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.